556 related articles for article (PubMed ID: 19586019)
21. Areneruthenium(II) 4-acyl-5-pyrazolonate derivatives: coordination chemistry, redox properties, and reactivity.
Marchetti F; Pettinari C; Pettinari R; Cerquetella A; Cingolani A; Chan EJ; Kozawa K; Skelton BW; White AH; Wanke R; Kuznetsov ML; Martins LM; Pombeiro AJ
Inorg Chem; 2007 Oct; 46(20):8245-57. PubMed ID: 17727269
[TBL] [Abstract][Full Text] [Related]
22. The dichotomy in the DNA-binding behaviour of ruthenium(II) complexes bearing benzoxazole and benzothiazole groups.
Spillane CB; Dabo MN; Fletcher NC; Morgan JL; Keene FR; Haq I; Buurma NJ
J Inorg Biochem; 2008 Apr; 102(4):673-83. PubMed ID: 18055017
[TBL] [Abstract][Full Text] [Related]
23. Half-sandwich RuII-[9]aneS3 complexes with dicarboxylate ligands: synthesis, characterization and chemical behavior.
Bratsos I; Birarda G; Jedner S; Zangrando E; Alessio E
Dalton Trans; 2007 Sep; (36):4048-58. PubMed ID: 17828366
[TBL] [Abstract][Full Text] [Related]
24. DNA binding and cytotoxicity of ruthenium(II) and rhenium(I) complexes of 2-amino-4-phenylamino-6-(2-pyridyl)-1,3,5-triazine.
Ma DL; Che CM; Siu FM; Yang M; Wong KY
Inorg Chem; 2007 Feb; 46(3):740-9. PubMed ID: 17257015
[TBL] [Abstract][Full Text] [Related]
25. DNA-binding studies of mixed-ligand (ethylenediamine)ruthenium(II) complexes.
Nagababu P; Latha JN; Satyanarayana S
Chem Biodivers; 2006 Nov; 3(11):1219-29. PubMed ID: 17193235
[TBL] [Abstract][Full Text] [Related]
26. Picolinate ruthenium(II)-arene complex with in vitro antiproliferative and antimetastatic properties: comparison to a series of ruthenium(II)-arene complexes with similar structure.
Gligorijević N; Aranđelović S; Filipović L; Jakovljević K; Janković R; Grgurić-Šipka S; Ivanović I; Radulović S; Tešić ZLj
J Inorg Biochem; 2012 Mar; 108():53-61. PubMed ID: 22266461
[TBL] [Abstract][Full Text] [Related]
27. meso-[{Ru(phen)2}2(mu-HAT)]4+: a high-affinity DNA hairpin probe {HAT = 1,4,5,8,9,12-hexaazatriphenylene; phen = 1,10-phenanthroline}.
Smith JA; Morgan JL; Turley AG; Collins JG; Keene FR
Dalton Trans; 2006 Jul; (26):3179-87. PubMed ID: 16802035
[TBL] [Abstract][Full Text] [Related]
28. Oligonuclear polypyridylruthenium(II) complexes incorporating flexible polar and non-polar bridges: synthesis, DNA-binding and cytotoxicity.
Mulyana Y; Weber DK; Buck DP; Motti CA; Collins JG; Keene FR
Dalton Trans; 2011 Feb; 40(7):1510-23. PubMed ID: 21218244
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, DNA-binding and photocleavage studies of [Ru(phen)2(pbtp)]2+ and [Ru(bpy)2(pbtp)]2+ (phen=1,10-phenanthroline; bpy=2,2'-bipyridine; pbtp=4,5,9,11,14-pentaaza-benzo[b]triphenylene).
Tan L; Xiao Y; Liu X; Zhang S
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Sep; 73(5):858-64. PubMed ID: 19497781
[TBL] [Abstract][Full Text] [Related]
30. Maltol-derived ruthenium-cymene complexes with tumor inhibiting properties: the impact of ligand-metal bond stability on anticancer activity in vitro.
Kandioller W; Hartinger CG; Nazarov AA; Bartel C; Skocic M; Jakupec MA; Arion VB; Keppler BK
Chemistry; 2009 Nov; 15(45):12283-91. PubMed ID: 19821465
[TBL] [Abstract][Full Text] [Related]
31. DNA binding and topoisomerase II inhibitory activity of water-soluble ruthenium(II) and rhodium(III) complexes.
Singh SK; Joshi S; Singh AR; Saxena JK; Pandey DS
Inorg Chem; 2007 Dec; 46(25):10869-76. PubMed ID: 18001110
[TBL] [Abstract][Full Text] [Related]
32. DNA interaction and cytotoxicity studies of new ruthenium(II) cyclopentadienyl derivative complexes containing heteroaromatic ligands.
Moreno V; Font-Bardia M; Calvet T; Lorenzo J; Avilés FX; Garcia MH; Morais TS; Valente A; Robalo MP
J Inorg Biochem; 2011 Feb; 105(2):241-9. PubMed ID: 21194624
[TBL] [Abstract][Full Text] [Related]
33. Ruthenium(II) complexes containing bis(2-(diphenylphosphino)phenyl) ether and their catalytic activity in hydrogenation reactions.
Venkateswaran R; Mague JT; Balakrishna MS
Inorg Chem; 2007 Feb; 46(3):809-17. PubMed ID: 17257024
[TBL] [Abstract][Full Text] [Related]
34. Ferrocenoyl pyridine arene ruthenium complexes with anticancer properties: synthesis, structure, electrochemistry, and cytotoxicity.
Auzias M; Therrien B; Süss-Fink G; Stepnicka P; Ang WH; Dyson PJ
Inorg Chem; 2008 Jan; 47(2):578-83. PubMed ID: 18085776
[TBL] [Abstract][Full Text] [Related]
35. Heteroleptic arene ruthenium complexes based on meso-substituted dipyrrins: synthesis, structure, reactivity, and electrochemical studies.
Yadav M; Singh AK; Maiti B; Pandey DS
Inorg Chem; 2009 Aug; 48(16):7593-603. PubMed ID: 19610658
[TBL] [Abstract][Full Text] [Related]
36. Preliminary chemico-biological studies on Ru(III) compounds with S-methyl pyrrolidine/dimethyl dithiocarbamate.
Giovagnini L; Mancinetti E; Ronconi L; Sitran S; Marchiò L; Castagliuolo I; Brun P; Trevisan A; Fregona D
J Inorg Biochem; 2009 May; 103(5):774-82. PubMed ID: 19250682
[TBL] [Abstract][Full Text] [Related]
37. Inert benzothiazole functionalised ruthenium(II) complexes; potential DNA hairpin binding agents.
Spillane CB; Morgan JL; Fletcher NC; Collins JG; Keene FR
Dalton Trans; 2006 Jul; (25):3122-33. PubMed ID: 16786071
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of cancer cell growth by ruthenium(II) cyclopentadienyl derivative complexes with heteroaromatic ligands.
Helena Garcia M; Morais TS; Florindo P; Piedade MF; Moreno V; Ciudad C; Noe V
J Inorg Biochem; 2009 Mar; 103(3):354-61. PubMed ID: 19128838
[TBL] [Abstract][Full Text] [Related]
39. Reaction of a (Salen)ruthenium(VI) nitrido complex with thiols. C-H bond activation by (Salen)ruthenium(IV) sulfilamido species.
Man WL; Lam WW; Kwong HK; Peng SM; Wong WT; Lau TC
Inorg Chem; 2010 Jan; 49(1):73-81. PubMed ID: 19954163
[TBL] [Abstract][Full Text] [Related]
40. Use of chelating ligands to tune the reactive site of half-sandwich ruthenium(II)-arene anticancer complexes.
Fernández R; Melchart M; Habtemariam A; Parsons S; Sadler PJ
Chemistry; 2004 Oct; 10(20):5173-9. PubMed ID: 15372674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
